These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 33888994)
1. Long Noncoding RNA ZEB1-AS1 Downregulates miR-23a, Promotes Tumor Progression, and Predicts the Survival of Oral Squamous Cell Carcinoma Patients. Wang X; Guo Y; Wang C; Wang Q; Yan G Onco Targets Ther; 2021; 14():2699-2710. PubMed ID: 33888994 [TBL] [Abstract][Full Text] [Related]
2. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition. Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486 [TBL] [Abstract][Full Text] [Related]
3. LncRNA INHBA-AS1 promotes cell growth, migration, and invasion of oral squamous cell carcinoma by sponging miR-143-3p. Ma WQ; Chen J; Fang W; Yang XQ; Zhu A; Zhang D; Zhong HL; Yang B; Luo Z Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1821-1828. PubMed ID: 32141551 [TBL] [Abstract][Full Text] [Related]
4. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a. Xu L; Hou TJ; Yang P Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6505-6515. PubMed ID: 31378890 [TBL] [Abstract][Full Text] [Related]
5. Long Non-Coding RNA PCED1B-AS1 Promotes the Progression of Clear Cell Renal Cell Carcinoma Through miR-484/ZEB1 Axis. Qin J; Zhu T; Wu W; Chen H; He Y Onco Targets Ther; 2021; 14():393-402. PubMed ID: 33469315 [TBL] [Abstract][Full Text] [Related]
6. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer. Ma T; Chen H; Wang P; Yang N; Bao J Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162 [No Abstract] [Full Text] [Related]
7. Knockdown of lncRNA ZNRD1-AS1 inhibits progression of bladder cancer by regulating miR-194 and ZEB1. Gao Z; Li S; Zhou X; Li H; He S Cancer Med; 2020 Oct; 9(20):7695-7705. PubMed ID: 32862492 [TBL] [Abstract][Full Text] [Related]
8. LncRNA TTN-AS1 promotes the progression of oral squamous cell carcinoma via miR-411-3p/NFAT5 axis. Fu SW; Zhang Y; Li S; Shi ZY; Zhao J; He QL Cancer Cell Int; 2020; 20():415. PubMed ID: 32863773 [TBL] [Abstract][Full Text] [Related]
9. LncRNA DS Cell Adhesion Molecule Antisense RNA 1 Facilitates Oral Squamous Cell Carcinoma Progression through The microRNA-138-5p/ Enhancer of Zeste 2 Polycomb Repressive Complex 2 Subunit Axis. Zhang Y; Wang X; Wang P; Zhang X; Han SH; Huo F Cell J; 2022 May; 24(5):222-229. PubMed ID: 35717565 [TBL] [Abstract][Full Text] [Related]
10. Long Non-Coding RNA TMPO-AS1 Promotes Cervical Cancer Cell Proliferation, Migration, and Invasion by Regulating miR-143-3p/ZEB1 Axis. Gang X; Yuan M; Zhang J Cancer Manag Res; 2020; 12():1587-1599. PubMed ID: 32184662 [TBL] [Abstract][Full Text] [Related]
11. LncRNA MCM3AP-AS1 promotes proliferation, migration and invasion of oral squamous cell carcinoma cells via regulating miR-204-5p/FOXC1. Li H; Jiang J J Investig Med; 2020 Oct; 68(7):1282-1288. PubMed ID: 32690597 [TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA ZEB1-AS1 promotes proliferation and metastasis of hepatocellular carcinoma cells by targeting miR-299-3p/E2F1 axis. Mu B; Lv C; Liu Q; Yang H J Biochem; 2021 Sep; 170(1):41-50. PubMed ID: 33788950 [TBL] [Abstract][Full Text] [Related]
13. LncRNA ZEB1-AS1 regulates hepatocellular carcinoma progression by targeting miR-23c. Xue S; Lu F; Sun C; Zhao J; Zhen H; Li X World J Surg Oncol; 2021 Apr; 19(1):121. PubMed ID: 33865414 [TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA OIP5-AS1 promotes the progression of oral squamous cell carcinoma via regulating miR-338-3p/NRP1 axis. Li M; Ning J; Li Z; Fei Q; Zhao C; Ge Y; Wang L Biomed Pharmacother; 2019 Oct; 118():109259. PubMed ID: 31369989 [TBL] [Abstract][Full Text] [Related]
15. LncRNA ZEB1-AS1 promotes pancreatic cancer progression by regulating miR-505-3p/TRIB2 axis. Wei G; Lu T; Shen J; Wang J Biochem Biophys Res Commun; 2020 Aug; 528(4):644-649. PubMed ID: 32513531 [TBL] [Abstract][Full Text] [Related]
16. LncRNA ZEB1-AS1 down-regulation suppresses the proliferation and invasion by inhibiting ZEB1 expression in oesophageal squamous cell carcinoma. Zhao Y; Wang N; Zhang X; Liu H; Yang S J Cell Mol Med; 2019 Dec; 23(12):8206-8218. PubMed ID: 31638344 [TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA ZEB1-AS1 promotes cell invasion and epithelial to mesenchymal transition through inducing ZEB1 expression in cervical cancer. Cheng R; Li N; Yang S; Liu L; Han S Onco Targets Ther; 2018; 11():7245-7253. PubMed ID: 30425516 [TBL] [Abstract][Full Text] [Related]
18. LncRNA HOXA11-AS promotes OSCC progression by sponging miR-98-5p to upregulate YBX2 expression. Niu X; Yang B; Liu F; Fang Q Biomed Pharmacother; 2020 Jan; 121():109623. PubMed ID: 31731187 [TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA ZEB1-AS1 indicates poor prognosis and promotes melanoma progression through targeting miR-1224-5p. Wang Q; Zhang R; Liu D Exp Ther Med; 2019 Jan; 17(1):857-862. PubMed ID: 30651872 [TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA OIP5-AS1 contributes to cisplatin resistance of oral squamous cell carcinoma through the miR-27b-3p/TRIM14 axis. Xiao Z; Li J; Jin Q; Liu D Exp Ther Med; 2021 Apr; 21(4):408. PubMed ID: 33692839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]